Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,843 total articles
Owens-Brockway Glass Container Inc., a wholly owned subsidiary of O-I Glass, Inc., announced the pricing of $500 million senior notes due 2033 with a 9.5% coupon to refinance existing debt. The proceeds from the offering, combined with other financing sources, will be used to redeem older notes due in 2027. The offering targets qualified institutio…
Dentsply Sirona has announced an enhanced distribution agreement with Atlanta Dental Supply, enabling the latter to offer Dentsply Sirona's digital dentistry technologies in the U.S. from August 1. This strategic move strengthens Dentsply Sirona's market presence in the Southeast and supports its focus on expanding digital dentistry offerings throu…
Aptera Motors Corp., a solar mobility company listed on NASDAQ under the ticker SEV, will present at the Emerging Growth Conference on May 6, 2026. The event provides a platform for the company to showcase its innovative solar electric vehicle technology and engage with shareholders and the investment community through a live online presentation an…
Osisko Development Corp. has appointed Sarah MacDonald as Vice President, Construction Contracting and Commercial. With over 18 years of legal and leadership experience in mining-related construction contracting and commercial arrangements, her addition aims to enhance the execution of Osisko's Cariboo Gold Project. The company focuses on developin…
MARA Holdings, Inc., a Nasdaq-listed digital infrastructure company, announced it will hold a webcast and conference call on May 11, 2026, to discuss its financial results for the quarter ended March 31, 2026. The company will also publish a shareholder letter with detailed results on its website prior to the call.
Telix Pharmaceuticals announced a new independent analysis of Phase 3 ZIRCON trial data published in European Urology, showing TLX250-Px (Zircaix®) PET/CT imaging is highly predictive of renal malignancies across all subtypes, not just clear cell renal cell carcinoma (ccRCC). The analysis reported high positive predictive value, sensitivity, and sp…
Ducommun Incorporated has appointed Mark A. Caylor, former Corporate Vice President and President of Northrop Grumman’s Mission Systems Sector, to its Board of Directors. This strategic move is part of Ducommun's Board refreshment program aligned with its VISION 2027 strategy, aimed at driving growth through organic and acquisition pathways. Mr. Ca…
Tango Therapeutics granted non-qualified stock options and restricted stock units to its CFO and a newly hired employee as inducements under its 2023 Inducement Plan, effective May 1, 2026. The awards have an exercise price set at the closing price on the grant date and vest over three to four years, aligning incentives with continued employment.
Pool Corporation has appointed John B. Watwood as its new President and CEO, effective May 4, 2026, succeeding Peter D. Arvan who is stepping down from his roles. John E. Stokely transitions to Executive Chair. The company remains on track with its full-year 2026 financial guidance and postpones its Investor Day event to a later date.
Eton Pharmaceuticals, a Nasdaq-listed pharmaceutical company focused on rare diseases, announced it will release its first quarter 2026 financial results on May 14, 2026. The company will host a live conference call and webcast for investors and stakeholders to discuss the results and answer questions. Eton currently markets ten rare disease produc…
Teva Pharmaceutical Industries Ltd. announced that Eric Hughes, EVP of Global R&D and Chief Medical Officer, will present at the BofA Securities Health Care Conference on May 12, 2026. The presentation will discuss company strategies, innovations in pharmaceuticals and provide insights into their product pipeline and market approach.
TOP Financial Group Limited announced it received a Nasdaq notification for failing to maintain the minimum $1.00 bid price for 30 consecutive business days. The company has 180 days to regain compliance or face potential delisting actions, including a possible reverse stock split. The notification does not affect current trading but signals risk i…
Bakkt, Inc., a regulated fintech company specializing in financial infrastructure, plans to release its first quarter 2026 earnings after market close on May 11, 2026. The company will host a conference call to discuss the results and answer investor questions, with a live webcast and related earnings materials accessible on its investor relations …
CVRx, Inc. has enrolled the first patient in its large-scale BENEFIT-HF trial, designed to evaluate the efficacy of its Barostim device in a significantly expanded heart failure population. The landmark randomized trial aims to enroll 2,500 patients across US and Germany centers, assessing all-cause mortality and heart failure decompensation events…
H&R Block announced a quarterly cash dividend of $0.42 per share payable in July 2026, reinforcing its long-standing history of dividend payments. The company has increased its dividend by 110% since 2016 and has returned over $5 billion to shareholders through dividends and share buybacks. H&R Block continues to provide tax preparation services an…
Cabot Corporation's Board of Directors declared a 5% increase in its quarterly dividend to $0.4725 per share, payable June 12, 2026. The raise highlights confidence in the company's strong cash flow, liquidity, and earnings durability, while maintaining investment capacity and a flexible balance sheet.
BioAge Labs, a clinical-stage biopharmaceutical company, will host an R&D Day webcast on May 8, 2026, presenting Phase 1 clinical data and the development rationale for BGE-102, a novel NLRP3 inflammasome inhibitor. The presentation includes insights from leading experts on NLRP3 biology and potential treatments for atherosclerotic cardiovascular d…
Unitil Corporation announced a net income of $33.2 million, or $1.85 EPS, for Q1 2026, reflecting a $5.7 million increase from Q1 2025. Adjusted net income, excluding transaction costs related to recent acquisitions, was $33.8 million or $1.88 EPS. The company experienced higher electric and gas gross margins driven by rate increases, customer grow…
Opus Genetics announced that its investigational gene therapy OPGx-LCA5 for Leber congenital amaurosis type 5 (LCA5), a rare inherited retinal disease, has been accepted into the FDA's Rare Disease Evidence Principles (RDEP) program. This acceptance supports collaboration with the FDA on regulatory strategy and clinical trial design, potentially ac…
Microvast Holdings, Inc., a leading developer of advanced battery technologies for electric vehicles and energy storage, announced it will release its Q1 2026 financial results after market close on May 11, 2026. A webcast and earnings call will follow to discuss business results and outlook. The company highlighted its 19-year legacy and extensive…
CRISPR Therapeutics AG reported its Q1 2026 financial results, highlighting $43 million in CASGEVY sales and ongoing expansion in approved markets. The company is progressing multiple clinical trials across autoimmune diseases, in vivo liver editing, and siRNA programs targeting major cardiovascular and immuno-oncology indications. Cash reserves in…
Cellectis, a clinical-stage biotech company specializing in gene editing and allogeneic CAR T immunotherapies, will report its Q1 2026 financial results on May 11, 2026 after US market close. The company will not host a conference call but remains available for investor inquiries.
Vornado Realty Trust announced its financial results for the first quarter ended March 31, 2026, reporting a net loss attributable to common shareholders of $22.8 million versus net income of $86.8 million in the prior year quarter. Funds From Operations (FFO) per share decreased to $0.49 from $0.67 in the prior year. The company continued active r…
Phoenix Asia Holdings Limited (NASDAQ: PHOE), primarily engaged in substructure works in Hong Kong, announced it has entered into a definitive Stock Acquisition Agreement to acquire 100% of ACEA Pharma, a clinical stage pharmaceutical company focused on cancer, autoimmune diseases, and Covid-19. Concurrently, the company issued a $20 million conver…
Great Elm Capital Corp. announced its first quarter 2026 financial results, highlighting a 13% increase in net investment income per share quarter-over-quarter, a strong liquidity position, and full redemption of notes due in June 2026. Jason Reese was appointed CEO, and the investment adviser waived accrued incentive fees to align interests with s…
